In a groundbreaking decision, President Trump is poised to sign an executive order reclassifying marijuana to Schedule III, easing federal restrictions and paving the way for vital medical research. This move aims to benefit Americans suffering from chronic pain and other conditions.
In a surprising announcement, Trump revealed plans to reclassify marijuana from a Schedule I to a Schedule III drug, which could significantly impact the cannabis market and investor interest. Experts predict that this change could take about a year, but optimism in the industry is rising.